The Linea IVT platform combines DNA IVT templates manufacturing via the Linea DNA platform with a proprietary Linea™ RNAP to enable mRNA and sa-mRNA manufacturers to produce what Applied DNA ...

We believe that Linea IVT supports the promise of mRNA and its potential to create a new generation of transformative medicines, such as mRNA therapeutics, vaccines, and personalized therapies." ...

We believe that Linea IVT supports the promise of mRNA and its potential to create a new generation of transformative medicines, such as mRNA therapeutics, vaccines, and personalized therapies." ...

Clay Shorrock, executive director of business development with LineaRx, an Applied DNA Sciences company, stated, "Therapy developers and CDMOs in our Linea IVT sales pipeline unanimously cite dsRNA ...

The CleanScribe enzyme drastically reduces dsRNA formation during IVT by up to 85% compared to wild-type T7 RNA Polymerase. "In this era of mRNA-based medicine, drug developers must streamline ...

As the first step in many workflows, in vitro transcription (IVT) has quickly emerged as an essential part of successful mRNA therapeutic manufacturing processes, optimizing and accelerating ...